Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer.

Lu Y, Gentiluomo M, Lorenzo-Bermejo J, Morelli L, Obazee O, Campa D, Canzian F.

J Med Genet. 2020 Feb 17. pii: jmedgenet-2019-106200. doi: 10.1136/jmedgenet-2019-106200. [Epub ahead of print]

PMID:
32066631
2.

Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort.

Gentiluomo M, Katzke VA, Kaaks R, Tjonneland A, Severi G, Perduca V, Boutron-Ruault MC, Weiderpass E, Ferrari P, Johnson T, Schulze MB, Bergmann M, Trichopoulou A, Karakatsani A, La Vecchia C, Palli D, Grioni S, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Vermeulen R, Sandanger TM, Quirós JR, Rodríguez-Barranco M, Amiano P, Colorado-Yohar S, Ardanaz E, Sund M, Khaw KT, Wareham NJ, Schmidt JA, Jakszyn P, Morelli L, Canzian F, Campa D.

Cancer Epidemiol Biomarkers Prev. 2020 Jan 13. pii: cebp.0868.2019. doi: 10.1158/1055-9965.EPI-19-0868. [Epub ahead of print]

PMID:
31932413
3.

Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.

Gentiluomo M, Peduzzi G, Lu Y, Campa D, Canzian F.

Mutagenesis. 2019 Dec 19;34(5-6):395-401. doi: 10.1093/mutage/gez040.

PMID:
31748817
4.

Genetic variants in taste-related genes and risk of pancreatic cancer.

Gentiluomo M, Lu Y, Canzian F, Campa D.

Mutagenesis. 2019 Dec 19;34(5-6):391-394. doi: 10.1093/mutage/gez032.

PMID:
31606007
5.

Inflammatory breast metastasis from primary advanced ovarian cancer.

Gentiluomo M, Villa C, Sommavilla E, Pesenti S, Parimbelli L, Bambina S, Valerii C, Sironi S.

Breast J. 2019 May;25(3):507-509. doi: 10.1111/tbj.13268. Epub 2019 Apr 10. No abstract available.

PMID:
30972858
6.

Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.

Gentiluomo M, Puchalt García P, Galeotti AA, Talar-Wojnarowska R, Tjaden C, Tavano F, Strobel O, Kupcinskas J, Neoptolemos J, Hegyi P, Costello E, Pezzilli R, Sperti C, Lawlor RT, Capurso G, Szentesi A, Soucek P, Vodicka P, Lovecek M, Hackert T, Cavestro GM, Milanetto AC, Canzian F, Campa D.

Carcinogenesis. 2019 Jun 10;40(4):544-550. doi: 10.1093/carcin/bgz006.

PMID:
30629142
7.

Taste receptor polymorphisms and male infertility.

Gentiluomo M, Crifasi L, Luddi A, Locci D, Barale R, Piomboni P, Campa D.

Hum Reprod. 2017 Nov 1;32(11):2324-2331. doi: 10.1093/humrep/dex305.

PMID:
29040583
8.

Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.

Campa D, Capurso G, Pastore M, Talar-Wojnarowska R, Milanetto AC, Landoni L, Maiello E, Lawlor RT, Malecka-Panas E, Funel N, Gazouli M, De Bonis A, Klüter H, Rinzivillo M, Delle Fave G, Hackert T, Landi S, Bugert P, Bambi F, Archibugi L, Scarpa A, Katzke V, Dervenis C, Liço V, Furlanello S, Strobel O, Tavano F, Basso D, Kaaks R, Pasquali C, Gentiluomo M, Rizzato C, Canzian F.

Sci Rep. 2016 Dec 23;6:39565. doi: 10.1038/srep39565.

9.

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.

Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bueno-de-Mesquita HB, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks R, Vashist Y, Gioffreda D, Strobel O, Shimizu Y, Dijk F, Andriulli A, Ivanauskas A, Bugert P, Tavano F, Vodickova L, Zambon CF, Lovecek M, Landi S, Key TJ, Boggi U, Pezzilli R, Jamroziak K, Mohelnikova-Duchonova B, Mambrini A, Bambi F, Busch O, Pazienza V, Valente R, Theodoropoulos GE, Hackert T, Capurso G, Cavestro GM, Pasquali C, Basso D, Sperti C, Matsuo K, Büchler M, Khaw KT, Izbicki J, Costello E, Katzke V, Michalski C, Stepien A, Rizzato C, Canzian F.

Oncotarget. 2016 Aug 30;7(35):57011-57020. doi: 10.18632/oncotarget.10935.

10.

Diarrhea as sole presentation of Good's syndrome mimicking Crohn's disease.

Mancuso A, Gentiluomo M, Vangeli M, Torre MD, Belli LS.

Clin Immunol. 2013 Apr;147(1):9-10. doi: 10.1016/j.clim.2013.01.012. Epub 2013 Feb 4. No abstract available.

PMID:
23454275
11.

Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature.

Zavaglia C, Airoldi A, Mancuso A, Vangeli M, Viganò R, Cordone G, Gentiluomo M, Belli LS.

Eur J Gastroenterol Hepatol. 2013 Feb;25(2):180-6. doi: 10.1097/MEG.0b013e328359e550. Review.

PMID:
23044808

Supplemental Content

Loading ...
Support Center